Inventor · disambiguated record
Jenna Goldberg
Also filed as: GOLDBERG JENNA
2 granted patents·10 pending applications·0 citations·filing 2021–2025
27Inventor score
Top patents by PatentIndex Score
12 records- 0169US2025362298A1Methods and compositions for monitoring the treatment of relapsed and/or refractory multiple myelomaJANSSEN BIOTECH INC·Filed 2025·Application pending·0 cites
- 0263US2025109211A1Methods of treating cancers and enhancing efficacy of bcmaxcd3 bispecific antibodiesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0361US2024352140A1Methods for treating multiple myelomaJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0459US2022373550A1Methods and compositions for monitoring the treatment of relapsed and/or refractory multiple myelomaJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 0558US12098210B2Methods of treating cancers and enhancing efficacy of BCMAxCD3 bispecific antibodiesJANSSEN BIOTECH INC·Filed 2022·Granted Sep 24, 2024·0 cites·10 claims
- 0655US11952426B2Methods for treating multiple myelomaJANSSEN BIOTECH INC·Filed 2021·Granted Apr 9, 2024·0 cites·13 claims
- 0752US2023061503A1Methods of minimizing neurotoxicity associated with chimeric antigen receptor (car) t cell therapyJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 0852US2025242019A2Methods for treating multiple myelomaJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0951US2024415960A1Methods for treating multiple myelomaJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1050US2024076376A1Approved products for the treatment of multiple myelomaJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1148US2022177584A1Methods for treating multiple myelomaJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1248US2023295292A1Methods of treating cancers and enhancing efficacy of gprc5dxcd3 bispecific antibodiesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jenna Goldberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →